These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 19121350)

  • 1. Nanoparticles for nasal vaccination.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles as carriers for nasal vaccine delivery.
    Köping-Höggård M; Sánchez A; Alonso MJ
    Expert Rev Vaccines; 2005 Apr; 4(2):185-96. PubMed ID: 15889992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal delivery of vaccines.
    Almeida AJ; Alpar HO
    J Drug Target; 1996; 3(6):455-67. PubMed ID: 8863138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles and microparticles as vaccine-delivery systems.
    Singh M; Chakrapani A; O'Hagan D
    Expert Rev Vaccines; 2007 Oct; 6(5):797-808. PubMed ID: 17931159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal vaccine innovation.
    Jabbal-Gill I
    J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2009 Mar; 98(3):812-43. PubMed ID: 18661544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPS nanoparticles as versatile delivery system to induce systemic and broad mucosal immunity after intranasal administration.
    Stano A; van der Vlies AJ; Martino MM; Swartz MA; Hubbell JA; Simeoni E
    Vaccine; 2011 Jan; 29(4):804-12. PubMed ID: 21094269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
    Csaba N; Sánchez A; Alonso MJ
    J Control Release; 2006 Jun; 113(2):164-72. PubMed ID: 16759732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
    Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral vaccination and vaccine-entrapped microparticle delivery system].
    Li FQ; Fei YB; Su H; Hu JH
    Yao Xue Xue Bao; 2007 Mar; 42(3):245-51. PubMed ID: 17520821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle size influences the magnitude and quality of mucosal immune responses after intranasal immunization.
    Stano A; Nembrini C; Swartz MA; Hubbell JA; Simeoni E
    Vaccine; 2012 Dec; 30(52):7541-6. PubMed ID: 23103199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of mucoadhesive polymers in nasal drug delivery.
    Jiang L; Gao L; Wang X; Tang L; Ma J
    Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal administration of plasmid DNA-coated nanoparticles results in enhanced immune responses.
    Cui Z; Mumper RJ
    J Pharm Pharmacol; 2002 Sep; 54(9):1195-203. PubMed ID: 12356273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology solutions for mucosal immunization.
    Chadwick S; Kriegel C; Amiji M
    Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomes as delivery systems for nasal vaccination: strategies and outcomes.
    Heurtault B; Frisch B; Pons F
    Expert Opin Drug Deliv; 2010 Jul; 7(7):829-44. PubMed ID: 20459361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems?
    Illum L
    J Pharm Sci; 2007 Mar; 96(3):473-83. PubMed ID: 17117404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer nanomicelles for efficient mucus delivery and antigen-specific high mucosal immunity.
    Noh YW; Hong JH; Shim SM; Park HS; Bae HH; Ryu EK; Hwang JH; Lee CH; Cho SH; Sung MH; Poo H; Lim YT
    Angew Chem Int Ed Engl; 2013 Jul; 52(30):7684-9. PubMed ID: 23765547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
    Salatin S; Barar J; Barzegar-Jalali M; Adibkia K; Milani MA; Jelvehgari M
    Arch Pharm Res; 2016 Sep; 39(9):1181-92. PubMed ID: 27352214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal Nanoparticulate Systems as Alternative Route of Drug Delivery.
    Alshweiat A; Ambrus R; Csoka I
    Curr Med Chem; 2019; 26(35):6459-6492. PubMed ID: 31453778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.